Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;45(10):5011-5021.
doi: 10.1007/s10072-024-07606-5. Epub 2024 May 25.

The assessment of the impact of antiepileptic drugs on cognitive functions via N-200/P-300 potentials and neuropsychological measures

Javid Shafiyev  1 , Ömer Karadaş  2
Affiliations

The assessment of the impact of antiepileptic drugs on cognitive functions via N-200/P-300 potentials and neuropsychological measures

Javid Shafiyev et al. Neurol Sci. 2024 Oct.

Abstract

Objective: The effects of antiseizure medications (ASMs) on cognitive functions have not been fully elucidated. The primary aim of this study was to demonstrate potential changes in cognitive functions in patients diagnosed with epilepsy from both neuropsychological and electrophysiological perspectives. Our secondary objective was to assess the effects of administered ASM on cognitive functions by categorizing patients into different monotherapy and polytherapy groups.

Materials and methods: A single-center, prospective patient registry study was conducted between May 2022 and June 2023. The inclusion criteria included epilepsy patients aged 18 to 50 years who were receiving ASM) treatment, either as inpatients or outpatients, and who did not have any syndromic diagnosis that may lead to cognitive disfunciton (such as primary progressive myoclonic epilepsies, Down syndrome and so on), and did not diagnosed previously or during examination that could affect dementia or cognitive functions. Patients who were scheduled to initiate new ASM treatment were evaluated using the Montreal Cognitive Assessment (MoCA) scale and Event-Related Potentials (ERP) assessment both before commencing treatment and three months thereafter.

Results: A total of 320 participants were included in the study; 20 healthy controls and 300 epilepsy patients were included. Statistically significant differences were observed between the healthy control group and the epilepsy group in terms of average Montreal Cognitive Assessment (MoCA) scores and event-related potentials (ERPs) (n200, p300 latencies, n2p3 amplitudes) (p<0.05). Similarly, statistically significant differences were observed between the monotherapy and polytherapy groups in terms of average MoCA and ERP scores (p<0.05).

Conclusion: This study demonstrated the detrimental effects of certain ASMs, particularly topiramate and carbamazepine, on cognitive functions. Furthermore, the negative impact on cognitive performance became more pronounced with an increasing number of concurrently used ASMs (polytherapy), with topiramate showing notable effects.

Keywords: Antiseizure medications; Cognition; Epilepsy; Event-related potentials; MoCA.

PubMed Disclaimer

Conflict of interest statement

There is no conflict of interest among the authors in the conduct of this study.

Figures

Fig. 1
Fig. 1
Linear regression analysis showing the effect of age on MoCA scores. MoCA: Montreal Cognitive Assessment. *The age has no effect on the MoCA score
See this image and copyright information in PMC

References

    1. Arroyo S, Dodson WE, Privitera MD, Glauser TA, Naritoku DK, Dlugos DJ, Wang S, Schwabe SK, Twyman RE (2005) Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol Scand 112(4):214–222. 10.1111/j.1600-0404.2005.00485.x - PubMed
    1. Beghi E (2020) The Epidemiology of Epilepsy. Neuroepidemiology 54(2):185–191. 10.1159/000503831 - PubMed
    1. Beghi E, Giussani G (2018) Aging and the Epidemiology of Epilepsy. Neuroendocrinology 51(3–4):216–223. 10.1159/000493484 - PubMed
    1. Carreño M, Donaire A, Sánchez-Carpintero R (2008) Cognitive disorders associated with epilepsy: Diagnosis and treatment. Neurologist 14(6 SUPPL. 1). 10.1097/01.nrl.0000340789.15295.8f - PubMed
    1. Duncan CC, Barry RJ, Connolly JF, Fischer C, Michie PT, Näätänen R, Polich J, Reinvang I, Van Petten C (2009) Event-related potentials in clinical research: Guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clin Neurophysiol 120(11):1883–1908. 10.1016/j.clinph.2009.07.045 - PubMed

Substances